BioFocus Announces Agreement with ChanTest

News   Feb 07, 2013

 
BioFocus Announces Agreement with ChanTest
 
 
 

RELATED ARTICLES

Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites

News

Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.

READ MORE

Epigenomic Analyses Could Lead to Novel Therapeutic Drug Targets for Many Diseases

News

Researchers have decoded the epigenetic landscape for rheumatoid arthritis (RA), In unveiling RA’s epigenome scientists made a surprising discovery: an overlap between the causes of RA and Huntington’s disease, a fatal and incurable genetic brain disease.

READ MORE

Combating Cancer by Targeting Sugar Receptors

News

Globally, cancer is the second leading cause of death, also because the efficiency of chemotherapeutics is inadequate due to poor delivery to the tumor. Prof. Olivia Merkel and her team develop targeted nanocarrier systems to increase the delivery rates of therapeutic formulations and their specific uptake into the target cells.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE